The challenged biotech firm, NovaGen Therapeutics, faced severe financial difficulties stemming from disappointing clinical trials and escalating debt. Their internal team lacked the experience to navigate https://alvinswwf009321.blog-gold.com/58453634/biotech-cfo-services-a-case-study-in-monetary-recovery